A recent study revealed the distinct spatial distribution of PD-L1- or PD-L1 + macrophages in ESCC and found the critical importance of the close distance between tumor cells and these antigen-presenting cells to the clinical outcome in patients receiving chemoradiotherapy combined with PD-1 blockade [30]. The gene discussed is CD274; the disease is neoplasm.